Acumen Medical Limited 07082142 false 2024-12-01 2025-11-30 2025-11-30 The principal activity of the company is the holding of investments. Digita Accounts Production Advanced 6.30.9574.0 true 07082142 2024-12-01 2025-11-30 07082142 2025-11-30 07082142 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 07082142 1 2025-11-30 07082142 bus:SmallEntities 2024-12-01 2025-11-30 07082142 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 07082142 bus:FilletedAccounts 2024-12-01 2025-11-30 07082142 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 07082142 bus:RegisteredOffice 2024-12-01 2025-11-30 07082142 bus:Director1 2024-12-01 2025-11-30 07082142 bus:Director2 2024-12-01 2025-11-30 07082142 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 07082142 countries:AllCountries 2024-12-01 2025-11-30 07082142 1 2024-12-01 2025-11-30 07082142 1 2024-11-30 07082142 2023-12-01 2024-11-30 07082142 2024-11-30 07082142 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 07082142 1 2024-11-30 07082142 1 2023-12-01 2024-11-30 07082142 1 2023-11-30 iso4217:GBP xbrli:pure

FINANCIAL PERIOD DATA REFRESH REQUIRED
Select the Refresh button on the Summary or Disclosure tab

Registration number: 07082142

Acumen Medical Limited
Unaudited Filleted Financial Statements
for the Year Ended 30 November 2025

Acumen Medical Limited

Contents

Statement of Financial Position | 1
Notes to the Unaudited Financial Statements | 2 to 4

Acumen Medical Limited

(Registration number: 07082142)
Statement of Financial Position as at 30 November 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Cash at bank and in hand |  | 3,099,031 | 3,085,887
Creditors: Amounts falling due within one year | 4 | (27,665) | (27,808)
Net assets |  | 3,071,366 | 3,058,079
Capital and reserves |  |  |
Called up share capital |  | 2 | 2
Profit and loss account |  | 3,071,364 | 3,058,077
Shareholders' funds |  | 3,071,366 | 3,058,079

For the financial year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of Comprehensive Income.

Approved and authorised by the Board on 4 February 2026 and signed on its behalf by:

Mrs M McLaren-Howard Director
Dr J McLaren-Howard Director

Acumen Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Timberly
South Street
Axminster
Devon
EX13 5AD

Principal activity

The principal activity of the company is the holding of investments.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Acumen Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025 (continued)

2 | Accounting policies (continued)

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. In the statement of financial position, bank overdrafts are shown within borrowing or current liabilities

Financial instruments

Recognition and measurement
A financial asset or a financial liability is recognised only when the company becomes party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

4 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 17,320 | 22,306
Accruals and deferred income | 1,914 | 1,286
Other creditors | 8,431 | 4,216
| 27,665 | 27,808

5 | Reserves

Profit and loss account:
This reserve records retained earnings and accumulated losses.

Acumen Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025 (continued)

6 | Related party transactions

Transactions with directors

2025 | At 1 December 2024 £ | Advances to director £ | Repayments by director £ | At 30 November 2025 £
| (4,216) | 41,785 | (46,000) | (8,431)

2024 | At 1 December 2023 £ | Advances to director £ | Repayments by director £ | At 30 November 2024 £
| 4,051 | 41,785 | (50,051) | (4,216)